Tzehoval E, Segal S, Zinberg N, Feldman M
J Immunol. 1984 Apr;132(4):1741-7.
We report the generation of macrophage-hybridomas, obtained by somatic cell fusion between macrophage-enriched C3H.eB spleen cell population, and a drug-resistant MPC-11 myeloma cell line, designated as 4T00.1L1 clone. Screening for hybridomas possessing macrophage properties was carried out by assaying the presence of two macrophage-specific enzymes: lysozyme and nonspecific esterase. Two hybridomas, E2-7 and E2-10, were selected for further studies. We found that clones of E2-7 (E2-7.7) did not express Fc receptors but possessed cell-surface Ia molecules. In contrast, clones of E2-10 (E2-10.20) possessed Fc receptors but were devoid of Ia molecules. E2-7.7 did, however, express Fc receptors after mitomycin treatment, whereas E2-10.20 eliminated the expression of Fc receptors after treatment with mitomycin C. Opsonized erythrocytes were phagocytized by E2-10.20 cells, but not by E2-7.7. Phagocytosis was thus correlated with the possession of Fc receptors. Testing the response of KLH-primed lymph node cells to KLH-pulsed hybridoma cells, we found that E2-7.7 cells caused antigen-specific lymphoproliferative response, whereas E2-10.20 did not. Thus, antigens could be presented by E2-7.7 but not by E2-10.20 cells. The response was shown to be mediated by T but not by B lymphocytes. The difference in antigen-presenting capacity could not be attributed to differences in antigen uptake by the different hybridomas, because the two hybridomas manifested the same level of pinocytosis. Both hybridomas produced IL1. The differences in the properties of the two hybridomas may indicate that the normal partners represent two distinct subpopulations of macrophages. The segregation of functional properties among the hybridoma clones may lead to a clarification of the dependence of distinct functions on defined molecular structures.
我们报告了巨噬细胞杂交瘤的产生,它是通过富含巨噬细胞的C3H.eB脾细胞群体与耐药性MPC - 11骨髓瘤细胞系进行体细胞融合获得的,命名为4T00.1L1克隆。通过检测两种巨噬细胞特异性酶(溶菌酶和非特异性酯酶)的存在来筛选具有巨噬细胞特性的杂交瘤。选择了两个杂交瘤E2 - 7和E2 - 10进行进一步研究。我们发现E2 - 7的克隆(E2 - 7.7)不表达Fc受体,但具有细胞表面Ia分子。相比之下,E2 - 10的克隆(E2 - 10.20)具有Fc受体,但没有Ia分子。然而,E2 - 7.7在丝裂霉素处理后表达Fc受体,而E2 - 10.20在用丝裂霉素C处理后消除了Fc受体的表达。调理素化的红细胞被E2 - 10.20细胞吞噬,但不被E2 - 7.7吞噬。因此,吞噬作用与Fc受体的拥有相关。测试经钥孔戚血蓝蛋白(KLH)致敏的淋巴结细胞对经KLH脉冲处理的杂交瘤细胞的反应,我们发现E2 - 7.7细胞引起抗原特异性淋巴细胞增殖反应,而E2 - 10.20则没有。因此,抗原可由E2 - 7.7细胞呈递,而不能由E2 - 10.20细胞呈递。该反应显示由T淋巴细胞而非B淋巴细胞介导。不同杂交瘤在抗原呈递能力上的差异不能归因于不同杂交瘤在抗原摄取上的差异,因为两种杂交瘤表现出相同水平的胞饮作用。两种杂交瘤都产生白细胞介素1(IL1)。两种杂交瘤特性的差异可能表明正常亲本代表巨噬细胞的两个不同亚群。杂交瘤克隆之间功能特性的分离可能有助于阐明不同功能对特定分子结构的依赖性。